|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 163.60 CHF | +0.25% |
|
+0.49% | +62.56% |
| Dec. 12 | Swiss stocks - Factors to watch on December 12 | RE |
| Dec. 11 | Galderma Enrolls Patients in Study of Chronic Pruritus of Unknown Origin Treatment | MT |
| Capitalization | 48.81B 41.58B 38.84B 36.54B 67.28B 4,421B 73.5B 453B 176B 2,084B 183B 179B 7,603B | P/E ratio 2025 * |
98.5x | P/E ratio 2026 * | 57.3x |
|---|---|---|---|---|---|
| Enterprise value | 50.82B 43.3B 40.44B 38.05B 70.06B 4,603B 76.54B 472B 183B 2,170B 191B 187B 7,917B | EV / Sales 2025 * |
9.59x | EV / Sales 2026 * | 8.04x |
| Free-Float |
35.38% | Yield 2025 * |
0.15% | Yield 2026 * | 0.28% |
Last Transcript: Galderma Group AG
| 1 day | +0.25% | ||
| 1 week | +0.49% | ||
| Current month | +2.25% | ||
| 1 month | +6.93% | ||
| 3 months | +12.21% | ||
| 6 months | +46.07% | ||
| Current year | +62.56% |
| 1 week | 162.2 | 170.1 | |
| 1 month | 143 | 170.1 | |
| Current year | 72.7 | 170.1 | |
| 1 year | 72.7 | 170.1 | |
| 3 years | 60 | 170.1 | |
| 5 years | 60 | 170.1 | |
| 10 years | 60 | 170.1 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.25% | +0.49% | +81.35% | - | 48.81B | ||
| -0.51% | -0.72% | +7.42% | +5.82% | 232B | ||
| +0.80% | +1.70% | -6.14% | +15.65% | 18.37B | ||
| +5.27% | +3.94% | -13.96% | -62.85% | 6.25B | ||
| 0.00% | -2.01% | +9.04% | -7.73% | 5.14B | ||
| -2.09% | -6.19% | -41.94% | +39.88% | 4.55B | ||
| +0.90% | -2.43% | +125.67% | - | 4.32B | ||
| -0.13% | -1.97% | -29.95% | -41.70% | 3.78B | ||
| -3.59% | -6.67% | -56.89% | -59.34% | 2.82B | ||
| +1.68% | +1.75% | -38.78% | -12.85% | 2.7B | ||
| Average | +0.26% | -1.12% | +3.58% | -15.39% | 32.83B | |
| Weighted average by Cap. | -0.21% | -0.46% | +16.78% | +3.72% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.2B 4.43B 4.14B 3.89B 7.17B 471B 7.83B 48.28B 18.73B 222B 19.5B 19.09B 810B | 6.17B 5.26B 4.91B 4.62B 8.5B 559B 9.29B 57.31B 22.23B 263B 23.15B 22.66B 961B |
| Net income | 552M 470M 439M 413M 761M 50B 831M 5.13B 1.99B 23.57B 2.07B 2.03B 85.99B | 891M 759M 709M 667M 1.23B 80.73B 1.34B 8.28B 3.21B 38.05B 3.34B 3.27B 139B |
| Net Debt | 2.02B 1.72B 1.6B 1.51B 2.78B 183B 3.04B 18.73B 7.27B 86.11B 7.57B 7.41B 314B | 1.25B 1.06B 993M 934M 1.72B 113B 1.88B 11.59B 4.5B 53.28B 4.68B 4.58B 194B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 163.60 CHF | +0.25% | 343,655 |
| 25-12-11 | 163.20 CHF | -2.74% | 359,711 |
| 25-12-10 | 167.80 CHF | +1.39% | 464,983 |
| 25-12-09 | 165.50 CHF | +0.61% | 343,034 |
| 25-12-08 | 164.50 CHF | +1.04% | 417,190 |
Delayed Quote Swiss Exchange, December 12, 2025 at 11:31 am EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GALD Stock
Select your edition
All financial news and data tailored to specific country editions
















